Can a Single Dose of Magic Mushrooms Reduce Anxiety and Depression in Life Threatening Cancer Patients?
A new study presented at the annual meeting of the American College of Neuropsychopharmacology concluded that a single dose of psilocybin, the major hallucinogenic compound in magic mushrooms. Induced decreases in depression and anxiety that lasted up to six months in patients with life threatening cancer. In the study the researchers studied the effects of psilocybin on them after receiving one dose significantly high enough to induce changes in perception and mystical type experiences. Patients reported significantly lower levels of anxiety and depression compared with patients who received a low dose of the drug and this positive effect lasted 6 months.